GlassScriptPhysician profile
Richard Dyer
NPI 1720676489
$953.54
in general payments reported to CMS, 2019-2025
17 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $130 · 2023: $81.71 · 2024: $351 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $164.04 | 2022-2025 | Airsupra |
| Lilly USA, LLC | $135.88 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $114.96 | 2024-2025 | |
| Sanofi Pasteur INC. | $89.25 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $77.00 | 2021 | |
| Welch Allyn | $67.84 | 2021 | |
| Novo Nordisk INC | $62.87 | 2024 | |
| Daiichi Sankyo INC. | $58.00 | 2024-2025 | Injectafer |
| Glaxosmithkline, LLC. | $32.09 | 2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Gilead Sciences, INC. | $30.32 | 2025 | |
| Biogen, INC. | $19.53 | 2025 | Spinraza, Skyclarys |
| Exact Sciences Corporation | $19.30 | 2024 | Cologuard Collection Kit |
| Pfizer INC. | $17.88 | 2024 | |
| Medicomp INC | $17.50 | 2025 | Telepatch Cardiac Monitor |
| Otsuka America Pharmaceutical, INC. | $17.29 | 2025 | Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.62 | 2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $14.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.